Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nurr1 Modulation Mediates Neuroprotective Effects of Statins
Sabine Willems, Julian A. Marschner, Whitney Kilu, et al.
Advanced Science (2022) Vol. 9, Iss. 18
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Protective effect of Nr4a2 (Nurr1) against LPS-induced depressive-like behaviors via regulating activity of microglia and CamkII neurons in anterior cingulate cortex
Yong He, Yue Wang, Heming Yu, et al.
Pharmacological Research (2023) Vol. 191, pp. 106717-106717
Open Access | Times Cited: 33
De Novo Design of Nurr1 Agonists via Fragment-Augmented Generative Deep Learning in Low-Data Regime
Marco Ballarotto, Sabine Willems, Tanja Stiller, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 12, pp. 8170-8177
Open Access | Times Cited: 31
Neurodegenerative Diseases: Unraveling the Heterogeneity of Astrocytes
Alberto Santiago-Balmaseda, Annai Aguirre-Orozco, Irais E. Valenzuela-Arzeta, et al.
Cells (2024) Vol. 13, Iss. 11, pp. 921-921
Open Access | Times Cited: 11
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications
Jan Vietor, Christian Gege, Tanja Stiller, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 9, pp. 6391-6402
Open Access | Times Cited: 21
Medicinal Chemistry and Chemical Biology of Nurr1 Modulators: An Emerging Strategy in Neurodegeneration
Sabine Willems, Daniel Merk
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9548-9563
Closed Access | Times Cited: 22
Inflammatory, metabolic, and sex-dependent gene-regulatory dynamics of microglia and macrophages in neonatal hippocampus after hypoxia-ischemia
Elena Di Martino, Anoop T. Ambikan, Daniel Ramsköld, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109346-109346
Open Access | Times Cited: 4
Opportunities and challenges in targeting orphan nuclear receptors
Laura Isigkeit, Daniel Merk
Chemical Communications (2023) Vol. 59, Iss. 31, pp. 4551-4561
Closed Access | Times Cited: 10
Chemogenomics for steroid hormone receptors (NR3)
Espen Schallmayer, Laura Isigkeit, Lewis Elson, et al.
Communications Chemistry (2025) Vol. 8, Iss. 1
Open Access
NURR1 Deficiency Is Associated to Altered Microglial Phenotype in Male Mice
Francesca Montarolo, Sarah Thielens, María Bové, et al.
Molecular Neurobiology (2025)
Open Access
Influence of statin intervention on peripheral neuropathy in patients treated with anticancer drugs identified from the insurer database
Fuka Aizawa, Kenta Yagi, Maki Sato, et al.
Journal of Pharmaceutical Health Care and Sciences (2025) Vol. 11, Iss. 1
Open Access
Structural and mechanistic profiling of Nurr1 modulation by vidofludimus enables structure-guided ligand design
Úrsula López-García, Jan Vietor, Julian A. Marschner, et al.
Communications Chemistry (2025) Vol. 8, Iss. 1
Open Access
A novel chemically engineered multifunctional statin conjugate as self-assembled nanoparticles inhibiting bile acid transporters
Kyeong-Ju Lee, Yoon-Mi Lee, Seong-Bin Yang, et al.
Journal of Controlled Release (2024) Vol. 372, pp. 885-900
Closed Access | Times Cited: 3
Downregulation of microRNA-145a-5p promotes steatosis-to-NASH progression through upregulation of Nr4a2
Bo Li, Ziyi Yang, Fei Mao, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 5, pp. 1096-1109
Closed Access | Times Cited: 7
Exploring Fatty Acid Mimetics as NR4A Ligands
Tanja Stiller, Daniel Merk
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15362-15369
Open Access | Times Cited: 7
Smoke and Spike: Benzo[a]pyrene Enhances SARS‐CoV‐2 Infection by Boosting NR4A2‐Induced ACE2 and TMPRSS2 Expression
Wenbin Liu, Yue Zhao, Junyan Fan, et al.
Advanced Science (2023) Vol. 10, Iss. 26
Open Access | Times Cited: 6
Structure-Guided Design of Nurr1 Agonists Derived from the Natural Ligand Dihydroxyindole
Minh Sai, Jan Vietor, Moritz Maria Kornmayer, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13556-13567
Open Access | Times Cited: 6
Natural products and synthetic analogs as selective orphan nuclear receptor 4A (NR4A) modulators.
Stephen Safe
PubMed (2024) Vol. 39, Iss. 5, pp. 543-556
Closed Access | Times Cited: 2
Structural Perspective of NR4A Nuclear Receptor Family and Their Potential Endogenous Ligands
Ryoichi Hashida, Takeshi Kawabata
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 3, pp. 580-590
Open Access | Times Cited: 1
NR4A2 as a Novel Target Gene for Developmental and Epileptic Encephalopathy: A Systematic Review of Related Disorders and Therapeutic Strategies
Alba Gabaldón-Albero, Sonia Mayo, Francisco Martı́nez
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5198-5198
Open Access | Times Cited: 1
Structural optimization of oxaprozin for selective inverse Nurr1 agonism
Sabine Willems, Romy Busch, Felix Nawa, et al.
(2024)
Open Access | Times Cited: 1
Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR‐1) Reveals Inverse NOR‐1 Agonists
Daniel Zaienne, Silvia Arifi, Julian A. Marschner, et al.
ChemMedChem (2022) Vol. 17, Iss. 16
Open Access | Times Cited: 6
Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor Agonists
Moritz Helmstädter, Simone Schierle, Laura Isigkeit, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10070-10070
Open Access | Times Cited: 4
Fragment-based discovery of orphan nuclear receptor Nur77/NGFI-B ligands
Silvia Arifi, Daniel Zaienne, Jan Heering, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106164-106164
Closed Access | Times Cited: 3
Development of Nurr1 agonists from amodiaquine by scaffold hopping and fragment growing
Minh Sai, Emily C. Hank, Hin-Man Tai, et al.
Communications Chemistry (2024) Vol. 7, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top